CN108065361A - 一种虾青素复合制剂 - Google Patents
一种虾青素复合制剂 Download PDFInfo
- Publication number
- CN108065361A CN108065361A CN201611000591.8A CN201611000591A CN108065361A CN 108065361 A CN108065361 A CN 108065361A CN 201611000591 A CN201611000591 A CN 201611000591A CN 108065361 A CN108065361 A CN 108065361A
- Authority
- CN
- China
- Prior art keywords
- parts
- oil
- astaxanthin
- compound formulation
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 28
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 27
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 27
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 27
- 238000009472 formulation Methods 0.000 title claims abstract description 17
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- -1 astaxanthin compound Chemical class 0.000 title claims abstract description 14
- 239000003921 oil Substances 0.000 claims abstract description 20
- 235000019198 oils Nutrition 0.000 claims abstract description 20
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 7
- 235000008524 evening primrose extract Nutrition 0.000 claims abstract description 6
- 239000010475 evening primrose oil Substances 0.000 claims abstract description 6
- 229940089020 evening primrose oil Drugs 0.000 claims abstract description 6
- 229940106134 krill oil Drugs 0.000 claims abstract description 6
- 240000008415 Lactuca sativa Species 0.000 claims abstract description 5
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 5
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 5
- 240000008042 Zea mays Species 0.000 claims abstract description 5
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims abstract description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 5
- 239000004359 castor oil Substances 0.000 claims abstract description 5
- 235000019438 castor oil Nutrition 0.000 claims abstract description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 5
- 235000009973 maize Nutrition 0.000 claims abstract description 5
- 239000003813 safflower oil Substances 0.000 claims abstract description 5
- 235000012045 salad Nutrition 0.000 claims abstract description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 5
- 239000011709 vitamin E Substances 0.000 claims abstract description 5
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 5
- 229940046009 vitamin E Drugs 0.000 claims abstract description 5
- 239000010497 wheat germ oil Substances 0.000 claims abstract description 5
- 235000021323 fish oil Nutrition 0.000 claims abstract description 4
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 2
- 239000007901 soft capsule Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 241000238557 Decapoda Species 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 239000003963 antioxidant agent Substances 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 235000006708 antioxidants Nutrition 0.000 abstract description 5
- 150000003254 radicals Chemical class 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- 229940083466 soybean lecithin Drugs 0.000 abstract description 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 description 4
- 241000736199 Paeonia Species 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001514 astaxanthins Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000010235 heart cancer Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明涉及一种虾青素复合制剂，其各组分重量份数分别为：虾青素粉15‑24份、月见草油2‑4份、玉米胚芽油2‑5份、蓖麻子油3‑8份、小麦胚芽油1‑3份、大豆卵磷脂0.5‑2份、牡丹籽油0.1‑0.8份、海狗油0.1‑0.6份、红花籽油1‑2份、南极磷虾油0.1‑0.4份、色拉油8‑20份、鱼油3‑7份、维生素E油0.01‑0.1份。本发明所选取的原料配伍科学合理，共同作用能起到抗氧化、清除自由基的作用，同时还有降压，强心作用，是高血压、冠心病患者的食疗佳品。原料优选自天然植物，安全无副作用。
Description
技术领域
本发明涉及一种保健食品，尤其是一种虾青素复合制剂。
背景技术
目前，市场上的虾青素保健食品，都是以虾青素为主要原料配以其他辅料制成的，没有复合其他抗氧化原料，效果单一，不明显。本发明的虾青素复合制剂复合了月见草油、蓖麻子油、南极磷虾油、鱼油等多种富含不饱和脂肪酸的原料，产品效果明显。
发明内容
本发明提供一种虾青素复合制剂，起到抗氧化、清除自由基的作用，原料来源于纯天然植物，可长期食用，无副作用。
本发明是以如下技术方案实现的：一种虾青素复合制剂，其特征在于它由下述重量份数的原料共同混合加工制成：虾青素粉15-24份、月见草油2-4份、玉米胚芽油2-5份、蓖麻子油3-8份、小麦胚芽油1-3份、大豆卵磷脂0.5-2份、牡丹籽油0.1-0.8份、海狗油0.1-0.6份、红花籽油1-2份、南极磷虾油0.1-0.4份、色拉油8-20份、鱼油3-7份、维生素E油0.01-0.1份。
所述的一种虾青素复合制剂，其选取的虾青素粉中虾青素的含量要大于80%，其剂型为软胶囊剂。
食用富含虾青素中的食物可以防止身体接触一种称为自由基的破坏分子。通过一个氧化的过程，自由基会对细胞造成伤害。长此以往，将有可能导致人体患上各种各样的慢性疾病。 一些研究表明从日常饮食中摄入足量的虾青素可能减少患上两种慢性疾病的危险——心脏病和癌症。
本发明在传统食疗的基础上，搭配新资源食品，科学配伍，服用方便。各原料的有效因子充分发挥协同增效作用，起到抗氧化清除自由基、美化皮肤的作用，不含有激素，没有刺激性作用，可长期食用，安全无毒副作用。
本发明的有益效果是：本发明是一种虾青素复合制剂，配方科学，原料易采购，制备简单，携带方便。其制备方法工艺合理，可操作性强，易实现规模化生产。
具体实施方式
下面结合实施例对本发明做进一步描述。
实施例1
一种虾青素复合制剂，该保健食品制备成软胶囊，其组分及重量份数为：虾青素含量大于80%的虾青素粉22份、月见草油3份、玉米胚芽油2份、蓖麻子油4份、小麦胚芽油3份、大豆卵磷脂1份、牡丹籽油0.6份、海狗油0.5份、红花籽油2份、南极磷虾油0.2份、色拉油12份、鱼油5份、维生素E油0.05份。将上述原料混合均匀，然后根据软胶囊常规制备工艺进行加工。
按照实施例配方，1000人进行试用，其中955人认为本发明在抗氧化美化皮肤方面具有显著的保健作用，满意率高达95.5%。
实施例2
一种虾青素复合制剂，该保健食品制备成软胶囊，其组分及重量份数为：虾青素含量大于80%的虾青素粉18份、月见草油2份、玉米胚芽油4份、蓖麻子油6份、小麦胚芽油1份、大豆卵磷脂2份、牡丹籽油0.4份、海狗油0.2份、红花籽油1份、南极磷虾油0.3份、色拉油16份、鱼油4份、维生素E油0.08份。将上述原料混合均匀，然后根据软胶囊常规制备工艺进行加工。
按照实施例配方，1000人进行试用，其中947人认为本发明在抗氧化美化皮肤方面具有显著的保健作用，满意率高达94.7%。
以上对本发明进行了详细介绍，以上实施例的说明只是用于帮助理解本发明。本领域的普通技术人员应当理解，可以对本发明的技术方案进行更动、润饰或者等同替换，而不脱离本发明技术方案的精神和范围，其均应属于本发明的权利要求保护范围当中。
Claims (3)
1.一种虾青素复合制剂，其特征在于它由下述重量份数的原料共同混合加工制成：虾青素粉15-24份、月见草油2-4份、玉米胚芽油2-5份、蓖麻子油3-8份、小麦胚芽油1-3份、大豆卵磷脂0.5-2份、牡丹籽油0.1-0.8份、海狗油0.1-0.6份、红花籽油1-2份、南极磷虾油0.1-0.4份、色拉油8-20份、鱼油3-7份、维生素E油0.01-0.1份。
2.根据权利要求1所述，一种虾青素复合制剂，其特征在于选取的虾青素粉其虾青素含量要大于80%。
3.根据权利要求1所述，一种虾青素复合制剂，其特征在于上述原料混合均匀后，经软胶囊胶皮包裹后制成软胶囊剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611000591.8A CN108065361A (zh) | 2016-11-14 | 2016-11-14 | 一种虾青素复合制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611000591.8A CN108065361A (zh) | 2016-11-14 | 2016-11-14 | 一种虾青素复合制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108065361A true CN108065361A (zh) | 2018-05-25 |
Family
ID=62161928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611000591.8A Withdrawn CN108065361A (zh) | 2016-11-14 | 2016-11-14 | 一种虾青素复合制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108065361A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109247574A (zh) * | 2018-11-26 | 2019-01-22 | 青岛浩然生物科技有限公司 | 一种天然虾青素和葛仙米复合粉剂的制作方法 |
| CN109481416A (zh) * | 2019-01-02 | 2019-03-19 | 陈丽娟 | 一种虾青素软胶囊 |
-
2016
- 2016-11-14 CN CN201611000591.8A patent/CN108065361A/zh not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109247574A (zh) * | 2018-11-26 | 2019-01-22 | 青岛浩然生物科技有限公司 | 一种天然虾青素和葛仙米复合粉剂的制作方法 |
| CN109481416A (zh) * | 2019-01-02 | 2019-03-19 | 陈丽娟 | 一种虾青素软胶囊 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gateau et al. | Carotenoids of microalgae used in food industry and medicine | |
| FG Cicero et al. | Effects of carotenoids on health: are all the same? Results from clinical trials | |
| EP0755633B1 (de) | Zwei-Phasen-Präparat | |
| EP1733720B1 (en) | Composition comprising reduced-form coenzyme q10 and carotenoid compound | |
| CN103719301A (zh) | 以虾青素油为主料的健康食品 | |
| US11576935B2 (en) | Non-winterized, standardized marine source oil products and methods of making thereof | |
| US20180042978A1 (en) | Method of treating photo-induced ocular fatigue and associated reduction in speed of ocular focus | |
| Gahlawat | Emerging new insights into significance and applications of Plant Pigments | |
| CN108065361A (zh) | 一种虾青素复合制剂 | |
| CN110839881A (zh) | 一种灵芝孢子油番茄红素软胶囊及其制作工艺 | |
| CN104382003A (zh) | 一种叶黄素越橘软胶囊及其制备方法 | |
| CN105146543A (zh) | 一种提高免疫力、治疗三高的磷虾油复方制剂 | |
| CN106266252A (zh) | 一种番茄红素茶油软胶囊及其制备方法 | |
| KR20030029254A (ko) | 기능성 식품 | |
| JP6646368B2 (ja) | 網膜保護組成物 | |
| CN101878914A (zh) | 沙棘复合油组合保健品及其制备方法 | |
| CN107173807A (zh) | 一种含藻类提取物的抗氧化保健营养组合物 | |
| KR20110127454A (ko) | 옥수수염 추출물, 표고버섯 추출물, 청고추 추출물 및 팥싹 추출물을 함유하는 항비만용 조성물 | |
| Shabbir et al. | Natural carotenoids: Weapon against life-style-related disorders | |
| CN105764499A (zh) | 包含dha及epa的软胶囊 | |
| JP2017002015A (ja) | サプリメント及びその製造方法 | |
| CN105685485A (zh) | 生产脑黄金鸡蛋的方法 | |
| KR101795692B1 (ko) | 황반색소 밀도유지용 복합제제의 제조방법 | |
| CN103190613A (zh) | 一种紫甘薯保健品组合物的制备方法 | |
| WO2019083732A1 (en) | COMPOSITION FOR THE TREATMENT OF PHOTO-INDUCED OCULAR FATIGUE AND THE ASSOCIATED REDUCTION OF OCULAR FOCUSING SPEED IN HUMAN BEINGS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180525 |